The identification, prevention and management of chronic disease risk factors and understanding impact on clinical outcomes is fundamental to improving health and well-being. The program of work encapsulated in this application utilises a number of research methods to advance our understanding and provide new directions for cardiovascular disease prevention and management.
Congenital aortic stenosis is a life-long condition caused by a narrowing of the aortic valve. It accounts for 2-6% of congenital heart disease, and if left untreated, results in heart failure and death. While several surgical and non-surgical interventions are available, the ideal treatment for this condition is unclear. My research aims to evaluate outcomes of aortic valve repair and compare it to other techniques.
Improving Outcomes In Heart Failure Through Basic, Clinical And Translational Research
Funder
National Health and Medical Research Council
Funding Amount
$951,005.00
Summary
Heart failure (HF) is a common, chronic cardiovascular condition characterised by a reduced capacity of the heart to function. Patients with HF have a poor quality of life and significantly reduced survival. My proposed programme of research will improve the understanding of heart failure (HF) and lead to better treatments.
Centre Of Research Excellence In Cardiovascular Outcomes Improvement
Funder
National Health and Medical Research Council
Funding Amount
$2,500,000.00
Summary
Quality, safety and the effectiveness of providing prevention and treatments to those with cardiovascular disease is the focus of research of the CRE in Cardiovascular Outcomes Improvement. Utilizing data derived from clinical registries and large patient databases of patients receiving various treatments for heart problems, we will investigate what factors are important in delivering cost-effective favorable outcomes. The centre will train future leaders in cardiovascular research focusing on
Clinical And Genetic Studies In Inherited Heart Diseases And Sudden Death
Funder
National Health and Medical Research Council
Funding Amount
$568,892.00
Summary
This 5-year research fellowship will focus on the identification of new genes in patients and families with inherited heart disease and sudden cardiac death. State-of-the-art genetic approaches will be used in linking our genetic findings with the clinical aspects of disease. This new clinical and genetic knowledge regarding inherited heart diseases and translation of these findings to improved diagnostic and therapeutic approaches will lead to better care of families with inherited heart diseas ....This 5-year research fellowship will focus on the identification of new genes in patients and families with inherited heart disease and sudden cardiac death. State-of-the-art genetic approaches will be used in linking our genetic findings with the clinical aspects of disease. This new clinical and genetic knowledge regarding inherited heart diseases and translation of these findings to improved diagnostic and therapeutic approaches will lead to better care of families with inherited heart diseases and prevention of sudden cardiac death.Read moreRead less
Shannon Entropy Mapping - AF Ablation From First Principles
Funder
National Health and Medical Research Council
Funding Amount
$439,589.00
Summary
Atrial fibrillation (AF) is the most common heart rhythm disorder in humans, and a rapidly growing epidemic in Australia. AF occurs because electrical circuits called rotors take over the top chambers of the heart. Until now, ablation procedures to target AF have not been able to specifically target rotors, which has meant operations are often long and arduous. This project uses new mathematical techniques we have developed to localise rotors driving AF, aiming to develop a faster safer and more ....Atrial fibrillation (AF) is the most common heart rhythm disorder in humans, and a rapidly growing epidemic in Australia. AF occurs because electrical circuits called rotors take over the top chambers of the heart. Until now, ablation procedures to target AF have not been able to specifically target rotors, which has meant operations are often long and arduous. This project uses new mathematical techniques we have developed to localise rotors driving AF, aiming to develop a faster safer and more effective AF ablation.Read moreRead less
Sex Differences In Long-Term Outcomes Of Young Patients With Acute Myocardial Infarction
Funder
National Health and Medical Research Council
Funding Amount
$333,900.00
Summary
Young women (?55 years) are more likely to die after having a heart attack and face more difficult recoveries compared to similar aged men. However the cause of this difference is unknown. This project seeks to improve the prevention, care and longer term outcomes for young women following a heart attack. Information obtained from will provide evidence-based and actionable information for physicians to inform and manage their patients so that we may ultimately improve the lives of young women.
Platelet Derived Growth Factor Mediated Activation And Rejuvenation Of Endogenous Cardiac Stem Cells
Funder
National Health and Medical Research Council
Funding Amount
$102,345.00
Summary
The burden of heart failure is underpinned by the heart’s limited capacity for self-repair after injury. Recent evidence shows that PDGF can improve heart function by activating and rejuvenating resident heart stem cells. This project will build on over a decade of preliminary work in mice, validating our results in a preclinical large animal model. Outcomes of this project include expedited progression of this promising therapy where thousands of heart failure patients could one-day benefit.
An Integrated General Practice And Pharmacy-based Intervention To Promote The Prescription And Use Of Appropriate Preventive Medications Among Individuals At High Cardiovascular Risk.
Funder
National Health and Medical Research Council
Funding Amount
$2,380,071.00
Summary
We will conduct a randomised controlled trial that combines three methods to reduce risk factors and improve outcomes for people with cardiovascular disease (CVD). The methods include administration of a polypill, a GP-focused point-of-care intervention, and a pharmacy-led intervention to improve commencement and persistence with taking medications. We expect that integrating these three approaches will lead to large reductions in CVD risk factor levels for participants.
Valvular heart disease is a common cause of heart failure. Identification of the genetic causes of valvular heart disease has important implications in our understanding of these heart diseases, as well as translating these genetic discoveries into better diagnostic and prevention strategies in at-risk families. This research proposal seeks to perform a comprehensive clinical and genetic investigation of individuals and families with the two most common valvular heart diseases, mitral valve prol ....Valvular heart disease is a common cause of heart failure. Identification of the genetic causes of valvular heart disease has important implications in our understanding of these heart diseases, as well as translating these genetic discoveries into better diagnostic and prevention strategies in at-risk families. This research proposal seeks to perform a comprehensive clinical and genetic investigation of individuals and families with the two most common valvular heart diseases, mitral valve prolapse and congenital bicuspid aortic valve.Read moreRead less